Blogs

UDI Compliance Automation: Managing Global Medical Device Databases in One Platform

September 1, 2026
AdobeStock_32026328.jpeg

Learn how automating UDI compliance across EUDAMED, GUDID, and other global registries reduces errors, saves time, and scales your market access strategy.

Since the FDA introduced the first binding UDI regulation in 2013, regulators across the EU, Switzerland, Australia, and beyond have built their own frameworks — each with distinct data models, submission formats, and deadlines. For manufacturers operating across multiple markets, managing this manually is no longer practical. Here is where it breaks down, what the landscape looks like today, and how automation addresses it. 

Where manual UDI management breaks down 

  • Format translation errors: EUDAMED requires Basic UDI-DI compliant data across over a hundred distinct attributes. The FDA's GUDID uses a different schema with several dozen. A valid record in one system can be rejected in another not because the product data is wrong, but because the format was not adapted correctly.
  • Data inconsistency across registries: When different team members handle submissions to different databases at different times, the same device often ends up with slightly different attribute values across registries. This is a problem that surfaces during hospital procurement or regulatory inspections.
  • No reliable change management: A labeling revision or a new UDI-DI can trigger update obligations across every market where the device is registered. Without a centralized system, tracking which registries are current relies on manual reminders and institutional knowledge.
  • Audit gaps: Manual workflows rarely produce the structured, timestamped change history regulators expect during inspections. Rebuilding that trail after the fact is time-consuming and often incomplete. 

The global UDI landscape 

UDI originated with the FDA's 2013 rule under 21 CFR Part 830. Core product data requirements overlap significantly across registries, which means a well-structured central data foundation can serve multiple markets at once. 

Market 

Database 

Key Deadline 

USA GUDID Required before market placement 
EU + EEA EUDAMED May 2026 (new) / Nov 2026 (existing) 
Switzerland Swissdamed Currently planned: July 2026 (PMS devices) / Dec 2026 (all others) 
Australia AusUDID Currently planned: Class III/IIb: Jul 2026 / IIa: Jul 2027 / I: Jul 2028 
China CUDID Class III/II: mandatory / Class I: Oct 2026 (per latest published timelines) 
Saudi Arabia Saudi-DI Required before market placement 

EUDAMED is the most structurally complex registry. Registration is required at two levels — the Basic UDI-DI (model level) and the UDI-DI (device level) — and the UDI module links directly to the Certificate module managed by notified bodies. The registry requires over a hundred data attributes, and the May 2026 mandatory deadline for newly placed devices is now close. 

Swissdamed follows a high-overlap data model with EUDAMED, meaning companies already compliant with the EU framework have significant groundwork to build from. Machine-to-machine upload capability is currently planned for 2026, with deadlines still subject to Swissmedic confirmation. 

AusUDID, introduced through Australian TGA legislation in 2025 (confirm exact citation against the TGA register before publishing), applies a phased timeline by device class, currently planned as noted in the table above. A local "sponsor" concept means UDI-DI records can be updated by different actors, adding coordination complexity for companies using local distributors. 

Markets including Brazil, South Korea, Canada, and the UAE are at various stages of UDI rollout. Manufacturers with a centralized data foundation today are better placed to absorb those expansions without rebuilding their compliance workflow from scratch. 

UDI automation: Why it is crucial for compliance

Centralized product content management
 

In a well-built setup, all product attributes live in one master record rather than across siloed ERP, PLM, and labeling systems. This matters because misaligned product information is one of the leading causes of submission rejections. When regulatory, quality, and supply chain teams reference the same dataset, errors are caught before they reach a regulator. 

Automated pre-submission validation
 

A capable platform checks data against the field requirements of each target registry before submission. For EUDAMED, that means validating across over a hundred required attributes at two registration levels. Catching errors at this stage prevents rejections and removes the manual checking burden from regulatory staff.  

Multi-registry syndication
 

Once a record is validated, it should reach EUDAMED, GUDID, Swissdamed, AusUDID, and other registries from the same place. An update to the master record then propagates across all connected registries, with no separate workflow per database. For teams managing large portfolios across multiple markets, this directly reduces the effort of compliance maintenance. 

ERP and PLM integration
 

Product attributes should flow automatically from internal systems into the compliance environment, removing manual re-entry and keeping regulatory data in sync with product development and manufacturing records. Internal attributes are mapped to healthcare-specific standards and validated before publication. 

GDSN connectivity
 

Hospitals and group purchasing organizations expect the same product data accuracy as regulators. GDSN connectivity lets validated product content flow from the same master record to trading partners across more than 40 certified data pools globally, so one submission flow serves both regulatory and commercial requirements. 

Real-time compliance dashboards
 

Teams need a consolidated view of submission status, validation errors, and upcoming deadlines across all markets. When every action is logged and timestamped, audit readiness becomes a part of the normal compliance process. 

How osapiens automates UDI compliance
 

osapiens has built its medical device solution along these lines.  

  • Product data arrives from existing ERP, PIM, and PLM systems, or through manual entry, spreadsheet upload, or a direct interface, and passes a validation layer before anything leaves the platform.  
  • Validated records are submitted through live connections to EUDAMED, FDA GUDID, Swissdamed, AusUDID, and further registries in Asia and the Middle East, alongside GDSN, hospitals, trading partners, and implant registries.  
  • Connections for markets still finalizing their frameworks, among them Canada, the United Kingdom, Singapore, South Korea, Brazil, and the United Arab Emirates, are already in preparation. 

osapiens’ UDI Guide: Your key to understanding global medical device compliance 

With EUDAMED mandatory since May 2026, Swissdamed since July 2026, and AusUDID phasing in, the window to build a solid data foundation is narrowing. Download the free guide Mastering Global UDI Compliance for a practical, market-by-market breakdown of what each registry requires and how to structure your data for scalable submissions.